BFM
SRPT icon

Boothbay Fund Management’s Sarepta Therapeutics SRPT Stock Holding History

Boothbay Fund Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-153,460
Closed -$2.74M – 2152
2025
Q2 		$2.62M Buy
153,460
+100,546
+190% +$4.29M 0.05% 436
2025
Q1 		$3.38M Buy
52,914
+43,363
+454% +$4.56M 0.09% 306
2024
Q4 		$1.16M Sell
9,551
-5,310
-36% -$651K 0.03% 599
2024
Q3 		$1.86M Sell
14,861
-42,478
-74% -$5.87M 0.04% 543
2024
Q2 		$9.06M Buy
57,339
+14,782
+35% +$1.9M 0.21% 84
2024
Q1 		$5.51M Sell
42,557
-15,192
-26% -$1.86M 0.11% 200
2023
Q4 		$5.57M Buy
57,749
+23,857
+70% +$2.29M 0.14% 174
2023
Q3 		$4.11M Buy
+33,892
New +$3.83M 0.1% 272
2023
Q2 		– Sell
-1,963
Closed -$253K – 2264
2023
Q1 		$271K Sell
1,963
-2,654
-57% -$344K 0.01% 1572
2022
Q4 		$598K Buy
4,617
+1,556
+51% +$180K 0.01% 1103
2022
Q3 		$338K Sell
3,061
-129
-4% -$13K 0.01% 1448
2022
Q2 		$239K Buy
+3,190
New +$235K 0.01% 1612
2019
Q2 		– Sell
-1,958
Closed -$238K – 880
2019
Q1 		$233K Buy
+1,958
New +$252K 0.02% 575
2016
Q4 		– Sell
-7,830
Closed -$314K – 922
2016
Q3 		$481K Buy
+7,830
New +$237K 0.1% 226

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Boothbay Fund Management's SRPT Position: Q3 2025 in Review

Boothbay Fund Management sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 153,460 shares — an estimated $2.74M sold.

Boothbay Fund Management first reported a position in SRPT in Q3 2016 and held it in 14 quarters. The position peaked at $9.06M in Q2 2024. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Boothbay Fund Management reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 153,460 Sarepta Therapeutics shares in Q3 2025, an estimated $2.74M.
  • Boothbay Fund Management first reported a position in Sarepta Therapeutics in Q3 2016 and held it in 14 quarters.
  • Boothbay Fund Management's Sarepta Therapeutics position peaked at $9.06M in Q2 2024.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.